ADUS vs. USPH: Which Stock Is the Better Value Option?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two companies is the best option for those looking for undervalued stocks?
Are Investors Undervaluing Addus HomeCare (ADUS) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is the Options Market Predicting a Spike in Addus HomeCare (ADUS) Stock?
Investors need to pay close attention to Addus HomeCare (ADUS) stock based on the movements in the options market lately.
ADUS or USPH: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors?
Addus HomeCare Corporation (ADUS) Q4 2024 Earnings Call Transcript
Addus HomeCare Corporation (ADUS) Q4 2024 Earnings Call Transcript
Here's What Key Metrics Tell Us About Addus HomeCare (ADUS) Q4 Earnings
While the top- and bottom-line numbers for Addus HomeCare (ADUS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Addus HomeCare (ADUS) Q4 Earnings Match Estimates
Addus HomeCare (ADUS) came out with quarterly earnings of $1.38 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.32 per share a year ago.
Down -16.38% in 4 Weeks, Here's Why You Should You Buy the Dip in Addus HomeCare (ADUS)
Addus HomeCare (ADUS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
3 Reasons Why Growth Investors Shouldn't Overlook Addus HomeCare (ADUS)
Addus HomeCare (ADUS) possesses solid growth attributes, which could help it handily outperform the market.
Should Value Investors Buy Addus HomeCare (ADUS) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Pick These 4 Stocks With Impressive Interest Coverage Ratios
DECK, BOOT, ADUS & ENSG's impressive interest coverage ratios highlight that these companies can withstand financial hardships.
Ahead of Addus HomeCare (ADUS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Addus HomeCare (ADUS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
